(Q48408074)

11 February 2018

title

Induction of human glioma-specific cytotoxic T-lymphocyte lines by autologous tumor stimulation and interleukin 2. (English)

1 reference

11 February 2018

author name string

S Miyatake

1

1 reference

11 February 2018

H Handa

2

1 reference

11 February 2018

J Yamashita

3

1 reference

11 February 2018

T Yamasaki

4

1 reference

11 February 2018

M Ueda

5

1 reference

11 February 2018

Y Namba

6

1 reference

11 February 2018

M Hanaoka

7

1 reference

11 February 2018

publication date

1 January 1986

1 reference

11 February 2018

Journal of Neuro-Oncology

published in

1 reference

11 February 2018

volume

4

1 reference

11 February 2018

issue

1

1 reference

11 February 2018

page(s)

55-64

1 reference

11 February 2018

https://scigraph.springernature.com/pub.10.1007/bf02158003

exact match

0 references

cites work

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

1 reference

12 December 2020

Correlation between lymphocyte-mediated auto-tumor reactivities and clinical course. I. Evaluation of 46 patients with sarcoma

1 reference

12 December 2020

Immunobiologic aspects of the brain and human gliomas. A review

1 reference

12 December 2020

Immunobiology of primary intracranial tumors. Part 5: Correlation of a lymphocyte index and clinical status.

1 reference

12 December 2020

Biological Activity of Recombinant Human Interleukin-2 Produced inEscherichia coli

1 reference

12 December 2020

Lysis of tumor biopsy cells by autologous T lymphocytes activated in mixed cultures and propagated with T cell growth factor.

1 reference

12 December 2020

Long term culture of tumour-specific cytotoxic T cells

1 reference

12 December 2020

Specificity of adoptive chemoimmunotherapy of established syngeneic tumors

1 reference

12 December 2020

Characterization of the lysis of fresh human solid tumors by autologous lymphocytes activated in vitro with phytohemagglutinin

1 reference

12 December 2020

[Cloning of mouse glioma-specific killer T cells]

1 reference

12 December 2020

Ia determinants on human T-cell subsets defined by monoclonal antibody. Activation stimuli required for expression

1 reference

12 December 2020

[A new experimental approach to the specific immunotherapy for malignant brain tumor. Immunobiological characterization of T-cell growth factor]

1 reference

12 December 2020

Adoptive immunotherapy of cancer: accomplishments and prospects

1 reference

12 December 2020

Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity

1 reference

12 December 2020

Specific immunoreactivity of hybridoma-secreted monoclonal anti-melanoma antibodies to cultured cells and freshly derived human cells

1 reference

12 December 2020

Immune surveillance and tumors of the nervous system

1 reference

12 December 2020

Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies

1 reference

12 December 2020

Specific adoptive therapy of established leukemia with syngeneic lymphocytes sequentially immunized in vivo and in vitro and nonspecifically expanded by culture with Interleukin 2

1 reference

12 December 2020

Clonal analysis of cytotoxic T cell response against human melanoma

1 reference

12 December 2020

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

1 reference

12 December 2020

Specific adoptive immunotherapy with tumor-specific cytotoxic T-lymphocyte clone for murine malignant gliomas.

1 reference

12 December 2020

Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage

1 reference

12 December 2020

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

12 December 2020

Brain Enolases as Specific Markers of Neuronal and Glial Cells

1 reference

12 December 2020

Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2

1 reference

12 December 2020

A soluble protein characteristic of the nervous system

1 reference

12 December 2020

The effect of T cell growth factor on the generation of cytolytic T cells

1 reference

12 December 2020

Specificity of auto-tumor cytotoxicity exerted by fresh, activated and propagated human T lymphocytes

1 reference

12 December 2020

Studies on cytotoxicity generated in human mixed lymphocyte cultures. I. Time course and target spectrum of several distinct concomitant cytotoxic activities

1 reference

12 December 2020

Immunological aspects of intrinsic glial tumors

1 reference

12 December 2020

A microassay for cell-mediated immunity

1 reference

12 December 2020

Expression of neuroectodermal antigens common to melanomas, gliomas, and neuroblastomas. I. Identification by monoclonal anti-melanoma and anti-glioma antibodies.

1 reference

12 December 2020

[Effects of TCGF (T-cell growth factor) on experimental malignant glioma-specific killer T-cell]

1 reference

12 December 2020

Purification and some characteristics of human T-cell growth factor from phytohemagglutinin-stimulated lymphocyte-conditioned media

1 reference

12 December 2020

Human glioma-associated antigens detected by monoclonal antibodies.

1 reference

12 December 2020

Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows

1 reference

12 December 2020

Specificity of lymphocyte-mediated cytotoxicity in patients with primary intracranial tumors

1 reference

12 December 2020

An acidic protein isolated from fibrous astrocytes

1 reference

12 December 2020

Surface markers of cloned human T cells with various cytolytic activities

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02158003

1 reference

11 February 2018

PubMed ID

3489081

1 reference

11 February 2018